Substance

ID:349045

Names and Identifiers
IUPAC Traditional name
astemizole
IUPAC name
1-[(4-fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-1,3-benzodiazol-2-amine
Synonyms
1-(4-Fluorobenzyl)-2-(1-[4-methoxyphenethyl]piperidin-4-yl)aminobenzimidazoleAstemizole
Registration numbers
CAS Number
EC Number
MDL Number
Properties
Physical Property
Apperance
powder
Solubility
DMSO: >20 mg/mL
Safety Information
GHS Pictograms
GHS07
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
GHS Precautionary statements
P261-P305+P351+P338
Storage Temperature
2-8°C
European Hazard Symbols
Harmful Harmful (Xn)
MSDS Link
Risk Statements
22-36/37/38
German water hazard class
3
RTECS
DD8968000
Storage Condition
desiccated
protect from light
GHS Signal Word
Warning
Safety Statements
26-36
GHS Hazard statements
H315-H319-H335
Product Information
Empirical Formula (Hill Notation)
C28H31FN4O
Purity
≥98% (HPLC)
Molecule Details
Biochem/physiol Actions
Astermizole is a potent hERG potassium channel blocker (IC50 of 0.9 nM) and may used as a pharmacological chaperone to correct folding defects and restore protein function for some mutated forms of hERG channels. It has also been studied for treatment of malaria, hERG and hEAG channel function in cancer and as a second generation antihistamine H-1 antagonist.
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. A2861.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data